[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global ADC Drug Substance Market Growth 2024-2030

January 2024 | 95 pages | ID: G7ACE0CFE701EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global ADC Drug Substance market size was valued at US$ million in 2023. With growing demand in downstream market, the ADC Drug Substance is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global ADC Drug Substance market. ADC Drug Substance are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of ADC Drug Substance. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the ADC Drug Substance market.

Key Features:

The report on ADC Drug Substance market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the ADC Drug Substance market. It may include historical data, market segmentation by Type (e.g., ADC Drug Substance Targeting Nectin-4, ADC Drug Substance Targeting Trop-2), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the ADC Drug Substance market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the ADC Drug Substance market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the ADC Drug Substance industry. This include advancements in ADC Drug Substance technology, ADC Drug Substance new entrants, ADC Drug Substance new investment, and other innovations that are shaping the future of ADC Drug Substance.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the ADC Drug Substance market. It includes factors influencing customer ' purchasing decisions, preferences for ADC Drug Substance product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the ADC Drug Substance market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting ADC Drug Substance market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the ADC Drug Substance market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the ADC Drug Substance industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the ADC Drug Substance market.

Market Segmentation:

ADC Drug Substance market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • ADC Drug Substance Targeting Nectin-4
  • ADC Drug Substance Targeting Trop-2
Segmentation by application
  • Drug R&D
  • Medical Research
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • TOT Biopharm International
  • Lonza Group AG
  • WuXi XDC Cayman
  • BrightGene Bio-Medical
  • Haoyuan Pharmaceutical
  • Pfizer
  • Roche
Key Questions Addressed in this Report

What is the 10-year outlook for the global ADC Drug Substance market?

What factors are driving ADC Drug Substance market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do ADC Drug Substance market opportunities vary by end market size?

How does ADC Drug Substance break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global ADC Drug Substance Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for ADC Drug Substance by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for ADC Drug Substance by Country/Region, 2019, 2023 & 2030
2.2 ADC Drug Substance Segment by Type
  2.2.1 ADC Drug Substance Targeting Nectin-4
  2.2.2 ADC Drug Substance Targeting Trop-2
2.3 ADC Drug Substance Sales by Type
  2.3.1 Global ADC Drug Substance Sales Market Share by Type (2019-2024)
  2.3.2 Global ADC Drug Substance Revenue and Market Share by Type (2019-2024)
  2.3.3 Global ADC Drug Substance Sale Price by Type (2019-2024)
2.4 ADC Drug Substance Segment by Application
  2.4.1 Drug R&D
  2.4.2 Medical Research
  2.4.3 Others
2.5 ADC Drug Substance Sales by Application
  2.5.1 Global ADC Drug Substance Sale Market Share by Application (2019-2024)
  2.5.2 Global ADC Drug Substance Revenue and Market Share by Application (2019-2024)
  2.5.3 Global ADC Drug Substance Sale Price by Application (2019-2024)

3 GLOBAL ADC DRUG SUBSTANCE BY COMPANY

3.1 Global ADC Drug Substance Breakdown Data by Company
  3.1.1 Global ADC Drug Substance Annual Sales by Company (2019-2024)
  3.1.2 Global ADC Drug Substance Sales Market Share by Company (2019-2024)
3.2 Global ADC Drug Substance Annual Revenue by Company (2019-2024)
  3.2.1 Global ADC Drug Substance Revenue by Company (2019-2024)
  3.2.2 Global ADC Drug Substance Revenue Market Share by Company (2019-2024)
3.3 Global ADC Drug Substance Sale Price by Company
3.4 Key Manufacturers ADC Drug Substance Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers ADC Drug Substance Product Location Distribution
  3.4.2 Players ADC Drug Substance Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ADC DRUG SUBSTANCE BY GEOGRAPHIC REGION

4.1 World Historic ADC Drug Substance Market Size by Geographic Region (2019-2024)
  4.1.1 Global ADC Drug Substance Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global ADC Drug Substance Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic ADC Drug Substance Market Size by Country/Region (2019-2024)
  4.2.1 Global ADC Drug Substance Annual Sales by Country/Region (2019-2024)
  4.2.2 Global ADC Drug Substance Annual Revenue by Country/Region (2019-2024)
4.3 Americas ADC Drug Substance Sales Growth
4.4 APAC ADC Drug Substance Sales Growth
4.5 Europe ADC Drug Substance Sales Growth
4.6 Middle East & Africa ADC Drug Substance Sales Growth

5 AMERICAS

5.1 Americas ADC Drug Substance Sales by Country
  5.1.1 Americas ADC Drug Substance Sales by Country (2019-2024)
  5.1.2 Americas ADC Drug Substance Revenue by Country (2019-2024)
5.2 Americas ADC Drug Substance Sales by Type
5.3 Americas ADC Drug Substance Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC ADC Drug Substance Sales by Region
  6.1.1 APAC ADC Drug Substance Sales by Region (2019-2024)
  6.1.2 APAC ADC Drug Substance Revenue by Region (2019-2024)
6.2 APAC ADC Drug Substance Sales by Type
6.3 APAC ADC Drug Substance Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe ADC Drug Substance by Country
  7.1.1 Europe ADC Drug Substance Sales by Country (2019-2024)
  7.1.2 Europe ADC Drug Substance Revenue by Country (2019-2024)
7.2 Europe ADC Drug Substance Sales by Type
7.3 Europe ADC Drug Substance Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa ADC Drug Substance by Country
  8.1.1 Middle East & Africa ADC Drug Substance Sales by Country (2019-2024)
  8.1.2 Middle East & Africa ADC Drug Substance Revenue by Country (2019-2024)
8.2 Middle East & Africa ADC Drug Substance Sales by Type
8.3 Middle East & Africa ADC Drug Substance Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ADC Drug Substance
10.3 Manufacturing Process Analysis of ADC Drug Substance
10.4 Industry Chain Structure of ADC Drug Substance

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 ADC Drug Substance Distributors
11.3 ADC Drug Substance Customer

12 WORLD FORECAST REVIEW FOR ADC DRUG SUBSTANCE BY GEOGRAPHIC REGION

12.1 Global ADC Drug Substance Market Size Forecast by Region
  12.1.1 Global ADC Drug Substance Forecast by Region (2025-2030)
  12.1.2 Global ADC Drug Substance Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global ADC Drug Substance Forecast by Type
12.7 Global ADC Drug Substance Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 TOT Biopharm International
  13.1.1 TOT Biopharm International Company Information
  13.1.2 TOT Biopharm International ADC Drug Substance Product Portfolios and Specifications
  13.1.3 TOT Biopharm International ADC Drug Substance Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 TOT Biopharm International Main Business Overview
  13.1.5 TOT Biopharm International Latest Developments
13.2 Lonza Group AG
  13.2.1 Lonza Group AG Company Information
  13.2.2 Lonza Group AG ADC Drug Substance Product Portfolios and Specifications
  13.2.3 Lonza Group AG ADC Drug Substance Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Lonza Group AG Main Business Overview
  13.2.5 Lonza Group AG Latest Developments
13.3 WuXi XDC Cayman
  13.3.1 WuXi XDC Cayman Company Information
  13.3.2 WuXi XDC Cayman ADC Drug Substance Product Portfolios and Specifications
  13.3.3 WuXi XDC Cayman ADC Drug Substance Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 WuXi XDC Cayman Main Business Overview
  13.3.5 WuXi XDC Cayman Latest Developments
13.4 BrightGene Bio-Medical
  13.4.1 BrightGene Bio-Medical Company Information
  13.4.2 BrightGene Bio-Medical ADC Drug Substance Product Portfolios and Specifications
  13.4.3 BrightGene Bio-Medical ADC Drug Substance Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 BrightGene Bio-Medical Main Business Overview
  13.4.5 BrightGene Bio-Medical Latest Developments
13.5 Haoyuan Pharmaceutical
  13.5.1 Haoyuan Pharmaceutical Company Information
  13.5.2 Haoyuan Pharmaceutical ADC Drug Substance Product Portfolios and Specifications
  13.5.3 Haoyuan Pharmaceutical ADC Drug Substance Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Haoyuan Pharmaceutical Main Business Overview
  13.5.5 Haoyuan Pharmaceutical Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer ADC Drug Substance Product Portfolios and Specifications
  13.6.3 Pfizer ADC Drug Substance Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Roche
  13.7.1 Roche Company Information
  13.7.2 Roche ADC Drug Substance Product Portfolios and Specifications
  13.7.3 Roche ADC Drug Substance Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Roche Main Business Overview
  13.7.5 Roche Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. ADC Drug Substance Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. ADC Drug Substance Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of ADC Drug Substance Targeting Nectin-4
Table 4. Major Players of ADC Drug Substance Targeting Trop-2
Table 5. Global ADC Drug Substance Sales by Type (2019-2024) & (Tons)
Table 6. Global ADC Drug Substance Sales Market Share by Type (2019-2024)
Table 7. Global ADC Drug Substance Revenue by Type (2019-2024) & ($ million)
Table 8. Global ADC Drug Substance Revenue Market Share by Type (2019-2024)
Table 9. Global ADC Drug Substance Sale Price by Type (2019-2024) & (US$/Ton)
Table 10. Global ADC Drug Substance Sales by Application (2019-2024) & (Tons)
Table 11. Global ADC Drug Substance Sales Market Share by Application (2019-2024)
Table 12. Global ADC Drug Substance Revenue by Application (2019-2024)
Table 13. Global ADC Drug Substance Revenue Market Share by Application (2019-2024)
Table 14. Global ADC Drug Substance Sale Price by Application (2019-2024) & (US$/Ton)
Table 15. Global ADC Drug Substance Sales by Company (2019-2024) & (Tons)
Table 16. Global ADC Drug Substance Sales Market Share by Company (2019-2024)
Table 17. Global ADC Drug Substance Revenue by Company (2019-2024) ($ Millions)
Table 18. Global ADC Drug Substance Revenue Market Share by Company (2019-2024)
Table 19. Global ADC Drug Substance Sale Price by Company (2019-2024) & (US$/Ton)
Table 20. Key Manufacturers ADC Drug Substance Producing Area Distribution and Sales Area
Table 21. Players ADC Drug Substance Products Offered
Table 22. ADC Drug Substance Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global ADC Drug Substance Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global ADC Drug Substance Sales Market Share Geographic Region (2019-2024)
Table 27. Global ADC Drug Substance Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global ADC Drug Substance Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global ADC Drug Substance Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global ADC Drug Substance Sales Market Share by Country/Region (2019-2024)
Table 31. Global ADC Drug Substance Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global ADC Drug Substance Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas ADC Drug Substance Sales by Country (2019-2024) & (Tons)
Table 34. Americas ADC Drug Substance Sales Market Share by Country (2019-2024)
Table 35. Americas ADC Drug Substance Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas ADC Drug Substance Revenue Market Share by Country (2019-2024)
Table 37. Americas ADC Drug Substance Sales by Type (2019-2024) & (Tons)
Table 38. Americas ADC Drug Substance Sales by Application (2019-2024) & (Tons)
Table 39. APAC ADC Drug Substance Sales by Region (2019-2024) & (Tons)
Table 40. APAC ADC Drug Substance Sales Market Share by Region (2019-2024)
Table 41. APAC ADC Drug Substance Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC ADC Drug Substance Revenue Market Share by Region (2019-2024)
Table 43. APAC ADC Drug Substance Sales by Type (2019-2024) & (Tons)
Table 44. APAC ADC Drug Substance Sales by Application (2019-2024) & (Tons)
Table 45. Europe ADC Drug Substance Sales by Country (2019-2024) & (Tons)
Table 46. Europe ADC Drug Substance Sales Market Share by Country (2019-2024)
Table 47. Europe ADC Drug Substance Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe ADC Drug Substance Revenue Market Share by Country (2019-2024)
Table 49. Europe ADC Drug Substance Sales by Type (2019-2024) & (Tons)
Table 50. Europe ADC Drug Substance Sales by Application (2019-2024) & (Tons)
Table 51. Middle East & Africa ADC Drug Substance Sales by Country (2019-2024) & (Tons)
Table 52. Middle East & Africa ADC Drug Substance Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa ADC Drug Substance Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa ADC Drug Substance Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa ADC Drug Substance Sales by Type (2019-2024) & (Tons)
Table 56. Middle East & Africa ADC Drug Substance Sales by Application (2019-2024) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of ADC Drug Substance
Table 58. Key Market Challenges & Risks of ADC Drug Substance
Table 59. Key Industry Trends of ADC Drug Substance
Table 60. ADC Drug Substance Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. ADC Drug Substance Distributors List
Table 63. ADC Drug Substance Customer List
Table 64. Global ADC Drug Substance Sales Forecast by Region (2025-2030) & (Tons)
Table 65. Global ADC Drug Substance Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas ADC Drug Substance Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Americas ADC Drug Substance Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC ADC Drug Substance Sales Forecast by Region (2025-2030) & (Tons)
Table 69. APAC ADC Drug Substance Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe ADC Drug Substance Sales Forecast by Country (2025-2030) & (Tons)
Table 71. Europe ADC Drug Substance Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa ADC Drug Substance Sales Forecast by Country (2025-2030) & (Tons)
Table 73. Middle East & Africa ADC Drug Substance Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global ADC Drug Substance Sales Forecast by Type (2025-2030) & (Tons)
Table 75. Global ADC Drug Substance Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global ADC Drug Substance Sales Forecast by Application (2025-2030) & (Tons)
Table 77. Global ADC Drug Substance Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. TOT Biopharm International Basic Information, ADC Drug Substance Manufacturing Base, Sales Area and Its Competitors
Table 79. TOT Biopharm International ADC Drug Substance Product Portfolios and Specifications
Table 80. TOT Biopharm International ADC Drug Substance Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 81. TOT Biopharm International Main Business
Table 82. TOT Biopharm International Latest Developments
Table 83. Lonza Group AG Basic Information, ADC Drug Substance Manufacturing Base, Sales Area and Its Competitors
Table 84. Lonza Group AG ADC Drug Substance Product Portfolios and Specifications
Table 85. Lonza Group AG ADC Drug Substance Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 86. Lonza Group AG Main Business
Table 87. Lonza Group AG Latest Developments
Table 88. WuXi XDC Cayman Basic Information, ADC Drug Substance Manufacturing Base, Sales Area and Its Competitors
Table 89. WuXi XDC Cayman ADC Drug Substance Product Portfolios and Specifications
Table 90. WuXi XDC Cayman ADC Drug Substance Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 91. WuXi XDC Cayman Main Business
Table 92. WuXi XDC Cayman Latest Developments
Table 93. BrightGene Bio-Medical Basic Information, ADC Drug Substance Manufacturing Base, Sales Area and Its Competitors
Table 94. BrightGene Bio-Medical ADC Drug Substance Product Portfolios and Specifications
Table 95. BrightGene Bio-Medical ADC Drug Substance Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 96. BrightGene Bio-Medical Main Business
Table 97. BrightGene Bio-Medical Latest Developments
Table 98. Haoyuan Pharmaceutical Basic Information, ADC Drug Substance Manufacturing Base, Sales Area and Its Competitors
Table 99. Haoyuan Pharmaceutical ADC Drug Substance Product Portfolios and Specifications
Table 100. Haoyuan Pharmaceutical ADC Drug Substance Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 101. Haoyuan Pharmaceutical Main Business
Table 102. Haoyuan Pharmaceutical Latest Developments
Table 103. Pfizer Basic Information, ADC Drug Substance Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer ADC Drug Substance Product Portfolios and Specifications
Table 105. Pfizer ADC Drug Substance Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Roche Basic Information, ADC Drug Substance Manufacturing Base, Sales Area and Its Competitors
Table 109. Roche ADC Drug Substance Product Portfolios and Specifications
Table 110. Roche ADC Drug Substance Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 111. Roche Main Business
Table 112. Roche Latest Developments

LIST OF FIGURES

Figure 1. Picture of ADC Drug Substance
Figure 2. ADC Drug Substance Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global ADC Drug Substance Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global ADC Drug Substance Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. ADC Drug Substance Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of ADC Drug Substance Targeting Nectin-4
Figure 10. Product Picture of ADC Drug Substance Targeting Trop-2
Figure 11. Global ADC Drug Substance Sales Market Share by Type in 2023
Figure 12. Global ADC Drug Substance Revenue Market Share by Type (2019-2024)
Figure 13. ADC Drug Substance Consumed in Drug R&D
Figure 14. Global ADC Drug Substance Market: Drug R&D (2019-2024) & (Tons)
Figure 15. ADC Drug Substance Consumed in Medical Research
Figure 16. Global ADC Drug Substance Market: Medical Research (2019-2024) & (Tons)
Figure 17. ADC Drug Substance Consumed in Others
Figure 18. Global ADC Drug Substance Market: Others (2019-2024) & (Tons)
Figure 19. Global ADC Drug Substance Sales Market Share by Application (2023)
Figure 20. Global ADC Drug Substance Revenue Market Share by Application in 2023
Figure 21. ADC Drug Substance Sales Market by Company in 2023 (Tons)
Figure 22. Global ADC Drug Substance Sales Market Share by Company in 2023
Figure 23. ADC Drug Substance Revenue Market by Company in 2023 ($ Million)
Figure 24. Global ADC Drug Substance Revenue Market Share by Company in 2023
Figure 25. Global ADC Drug Substance Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global ADC Drug Substance Revenue Market Share by Geographic Region in 2023
Figure 27. Americas ADC Drug Substance Sales 2019-2024 (Tons)
Figure 28. Americas ADC Drug Substance Revenue 2019-2024 ($ Millions)
Figure 29. APAC ADC Drug Substance Sales 2019-2024 (Tons)
Figure 30. APAC ADC Drug Substance Revenue 2019-2024 ($ Millions)
Figure 31. Europe ADC Drug Substance Sales 2019-2024 (Tons)
Figure 32. Europe ADC Drug Substance Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa ADC Drug Substance Sales 2019-2024 (Tons)
Figure 34. Middle East & Africa ADC Drug Substance Revenue 2019-2024 ($ Millions)
Figure 35. Americas ADC Drug Substance Sales Market Share by Country in 2023
Figure 36. Americas ADC Drug Substance Revenue Market Share by Country in 2023
Figure 37. Americas ADC Drug Substance Sales Market Share by Type (2019-2024)
Figure 38. Americas ADC Drug Substance Sales Market Share by Application (2019-2024)
Figure 39. United States ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC ADC Drug Substance Sales Market Share by Region in 2023
Figure 44. APAC ADC Drug Substance Revenue Market Share by Regions in 2023
Figure 45. APAC ADC Drug Substance Sales Market Share by Type (2019-2024)
Figure 46. APAC ADC Drug Substance Sales Market Share by Application (2019-2024)
Figure 47. China ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 51. India ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe ADC Drug Substance Sales Market Share by Country in 2023
Figure 55. Europe ADC Drug Substance Revenue Market Share by Country in 2023
Figure 56. Europe ADC Drug Substance Sales Market Share by Type (2019-2024)
Figure 57. Europe ADC Drug Substance Sales Market Share by Application (2019-2024)
Figure 58. Germany ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 59. France ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa ADC Drug Substance Sales Market Share by Country in 2023
Figure 64. Middle East & Africa ADC Drug Substance Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa ADC Drug Substance Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa ADC Drug Substance Sales Market Share by Application (2019-2024)
Figure 67. Egypt ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country ADC Drug Substance Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of ADC Drug Substance in 2023
Figure 73. Manufacturing Process Analysis of ADC Drug Substance
Figure 74. Industry Chain Structure of ADC Drug Substance
Figure 75. Channels of Distribution
Figure 76. Global ADC Drug Substance Sales Market Forecast by Region (2025-2030)
Figure 77. Global ADC Drug Substance Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global ADC Drug Substance Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global ADC Drug Substance Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global ADC Drug Substance Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global ADC Drug Substance Revenue Market Share Forecast by Application (2025-2030)


More Publications